Suppr超能文献

相似文献

2
Pdx1 restores beta cell function in Irs2 knockout mice.
J Clin Invest. 2002 May;109(9):1193-201. doi: 10.1172/JCI14439.
4
FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization.
PLoS One. 2012;7(2):e32249. doi: 10.1371/journal.pone.0032249. Epub 2012 Feb 23.
5
FoxO1 as a double-edged sword in the pancreas: analysis of pancreas- and β-cell-specific FoxO1 knockout mice.
Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E603-13. doi: 10.1152/ajpendo.00469.2011. Epub 2012 Jan 3.
7
A transcription factor regulatory circuit in differentiated pancreatic cells.
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14481-6. doi: 10.1073/pnas.241349398. Epub 2001 Nov 20.
8
The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Mol Endocrinol. 2006 Dec;20(12):3389-99. doi: 10.1210/me.2006-0092. Epub 2006 Aug 17.
9
FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
Endocrinology. 2016 Mar;157(3):1055-70. doi: 10.1210/en.2015-1852. Epub 2016 Jan 4.
10
Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).
J Biol Chem. 2011 Apr 15;286(15):13647-56. doi: 10.1074/jbc.M110.204248. Epub 2011 Feb 18.

引用本文的文献

2
Role of SIRT3 in the regulation of Gadd45α expression and DNA repair in β-cells.
J Biol Chem. 2025 Mar 25;301(5):108451. doi: 10.1016/j.jbc.2025.108451.
4
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.
Front Endocrinol (Lausanne). 2023 Oct 23;14:1286838. doi: 10.3389/fendo.2023.1286838. eCollection 2023.
5
Protective effects of curcumin on desipramine-induced islet β-cell damage via AKAP150/PKA/PP2B complex.
Acta Pharmacol Sin. 2024 Feb;45(2):327-338. doi: 10.1038/s41401-023-01176-6. Epub 2023 Oct 16.
6
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.
J Clin Invest. 2023 Sep 15;133(18):e166490. doi: 10.1172/JCI166490.
8
Signaling pathways and intervention for therapy of type 2 diabetes mellitus.
MedComm (2020). 2023 Jun 7;4(3):e283. doi: 10.1002/mco2.283. eCollection 2023 Jun.

本文引用的文献

1
Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor.
J Clin Invest. 2002 Oct;110(7):1011-9. doi: 10.1172/JCI15276.
3
Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo.
Diabetes. 2002 Aug;51(8):2546-51. doi: 10.2337/diabetes.51.8.2546.
4
Pdx1 restores beta cell function in Irs2 knockout mice.
J Clin Invest. 2002 May;109(9):1193-201. doi: 10.1172/JCI14439.
7
Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus.
Nat Genet. 2002 Apr;30(4):430-5. doi: 10.1038/ng860. Epub 2002 Mar 25.
8
Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion.
J Biol Chem. 2002 Mar 29;277(13):11225-32. doi: 10.1074/jbc.M111272200. Epub 2002 Jan 7.
9
Insulin signalling and the regulation of glucose and lipid metabolism.
Nature. 2001 Dec 13;414(6865):799-806. doi: 10.1038/414799a.
10
Diabetes mellitus and genetically programmed defects in beta-cell function.
Nature. 2001 Dec 13;414(6865):788-91. doi: 10.1038/414788a.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验